| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0056 | 0.9 |